Genetic key to milder COVID: Certain genes slash severity and death risk in older men

Study found that certain genetic variants in the IL1RN gene significantly reduce COVID-19-related inflammation and mortality in patients, with notable improvements observed in older men carrying specific single-nucleotide variants.

IA-2A positivity identified as a key predictor in type 1 diabetes progression

A recent study published in Diabetologia has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant marker for disease progression in individuals at risk

March 10, 2025

IVF bans like Alabama’s could cost the lives of children already born

When my wife, Laurie, completed her ninth in vitro fertilization cycle in the spring of 2000, we had more than 150 fertilized embryos in frozen

February 27, 2024

What Does FDA Expect from Lykos’ Next Phase 3 MDMA Study? (Part 2) – Psychedelic Alpha

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.